Abstract
Since 1975 the authors have been using Loxapine Succinate/ Hydrochloride [Loxitane (R)] in a variety of psychotic disorders such as Acute and Paranoid Schizophrenia, Bipolar Disorder, specifically the Manic Phase, in conjunction with Lithium Carbonate, Acute and Chronic Brain disorder and/or any psychotic disorder where loss of contact with reality (delusions and hallucinations) and agitation are cardinal symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Davis, J.M. and Casper, R.: Antipsychotic drugs; Clinical Pharmacology and therapeutic use. Drugs 14: 260–282. 1977.
Ayd FJ Jr. Loxapine update: 1966–1976. Dis Nerv Syst 38:883–887, 1977.
Gomez, E., “Comparison of Loxapine, Chlorpromazine and Placebo,” Grand Rounds, George London Mem. Hosp. Chicago, IL, June 1976,
Gomez, E., “Loxapine vs. Haloperidol, Clinical Observations in Acute Schizophrenia,” paper read at Clinical Conference, George London Memorial Hospital, Chicago, IL, November 1976.
Arce, A., Torres-Matrullo, C, “Acculturation: Its Impact on Treatment Strategies,” paper read “The Hispanic American Symposium,” A.P.A. Annual Meeting, Atlanta, GA, May 1978.
Gomez, E., “Clinical Observations In The Treatment of Tardive Dyskinesia with Dihydrogenated Ergot Alkaloids (Hydergine), Preliminary Findings,” Psych. J. Univ. Ottawa, Vol. II, No. 2, July 1977.
Gomez, E., “The Chronic Patient, Patterns of Rehabilitation,” paper read to the Faculty Ottawa University — School of Medicine, Dept. of Psychiatry, Ottawa, Canada, March 1982.
Hollister, L.E.: Uses of Psychotherapeutic Drugs. Ann. Int. Med. 79:88–98, 1973.
Tune, LE, McHugh PR, Coyle JT: Management of extrapyramidal side effects. induced by neuroleptics. Johns Hopkins Med J 148:149–153, 1981.
Cole, J. O.: Therapeutic approaches to tardive dyskinesia. Arch. Gen. Psychiat. 27:491–499, 1972.
Weidley EF, Setler PE, Rush JA:
Clark ML, Paredes A. Costiloe JP, et al: Loxapine in newly admitted chronic schizophrenic patients. J Clin Pharmacol 15:286–292, 1975.
Gomez, M., Gomez, E., “Hispanics in Treatment: The Amoxapine Experience,” paper read at the Symposium “The Treatment of Hispanic Patients in the U.S.A.” at the VII World Congress of Psychiatry, Vienna, Austria, July 198.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gomez, E., Gomez, M. (1985). Hispanics in Treatment: The Loxapine Experience. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Psychiatry The State of the Art. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1853-9_75
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1853-9_75
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1855-3
Online ISBN: 978-1-4757-1853-9
eBook Packages: Springer Book Archive